News
Surgical bleeding risk ‘remarkable’ with platelet disorders
Key clinical point: Inherited platelet function disorders are associated with a significant surgical bleeding risk. Major finding: The frequency...
News
Advanced age no barrier to continuous myeloma regimen
Key clinical point: Patients over age 75 draw the same survival benefit with continuous lenalidomide plus low-dose dexamethasone over MPT as their...
News
Transdermal testosterone tanks in poor ovarian responders
Pretreatment with transdermal testosterone failed to improve outcomes in women with poor ovarian response undergoing intra-cytoplasmic sperm...
News
Letrozole bests clomiphene again in infertile women with PCOS
The aromatase inhibitor letrozole was associated with roughly a 42% increase in the pregnancy rate, compared with clomiphene citrate in infertile...
News
ESHRE: Ectopic pregnancy rate with ART tumbles over time
The rate of ectopic pregnancy following conception with assisted reproductive technology has declined from 20 to 12 cases per thousand in a...
News
ESHRE: ART does not hurt academic performance in teens
Conception through assisted reproductive technology is not associated with lower academic performance in adolescence, according to a Danish...
News
ESHRE: ART Does Not Hurt Academic Performance in Teens
Key clinical point: Conception by assisted reproductive technology is not associated with poorer academic performance in adolescence. Major...
News
EHA: Inotuzumab rallies against refractory/relapsed ALL
Key clinical point: Inotuzumab ozagamicin shows promise as a new treatment option for relapsed or refractory acute lymphoblastic leukemia. Major...
News
EHA: Dasatinib gets early edge over imatinib in CML
Key clinical point: Dasatinib provides more molecular responses than imatinib, but no survival advantage at 2 years in the first-line treatment of...
News
EHA: Venetoclax-rituxumab combo highly active in relapsed/refractory CLL
Key clinical point: Venetoclax plus rituximab is a highly active nonchemotherapy combination for patients with relapsed or refractory chronic...
News
DDW: Top-down Crohn’s treatment holds up with longer scrutiny
A new strategy that has been proposed with the aim of altering the disease course and slow progression of Crohn’s disease by reversing the...
News
ASCO: Ascites may salvage trebananib in recurrent ovarian cancer
Key clinical point: The combination of paclitaxel plus trebananib may be useful in women with recurrent ovarian cancer and ascites. Major finding...
News
ASCO: Research IDs new subtype of refractory prostate cancer
Key clinical point: Researchers have identified an aggressive new histologic subset of metastatic castration-resistant prostate cancer. Major...
News
SVR Rates Slump With Real-world Use of Sofosbuvir-based HCV Regimens
Key clinical point: The percentage of patients achieving remission was lower in routine clinical practice with sofosbuvir-based regimens than in...
